Amlodipine News and Research

RSS
Brazilian researchers propose new way for treating thalassemia major

Brazilian researchers propose new way for treating thalassemia major

Atomic level analysis reveals how two classes of calcium channel blockers produce different effects

Atomic level analysis reveals how two classes of calcium channel blockers produce different effects

Pharmacotherapy reduces conduction system disease risk

Pharmacotherapy reduces conduction system disease risk

Kitov announces more data from Phase III trial on the favorable blood pressure effects of KIT-302

Kitov announces more data from Phase III trial on the favorable blood pressure effects of KIT-302

Kitov Pharmaceuticals' KIT-302 drug candidate meets primary efficacy endpoint in Phase III clinical trial

Kitov Pharmaceuticals' KIT-302 drug candidate meets primary efficacy endpoint in Phase III clinical trial

Mylan announces U.S. launch of Amlodipine and Valsartan Tablets

Mylan announces U.S. launch of Amlodipine and Valsartan Tablets

Par Pharmaceutical starts shipping generic version of Exforge

Par Pharmaceutical starts shipping generic version of Exforge

FDA accepts Symplmed's Prestalia NDA for hypertension treatment

FDA accepts Symplmed's Prestalia NDA for hypertension treatment

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Dr. Reddy's Laboratories launches Amlodipine Besylate and Atorvastatin Calcium Tablets

Dr. Reddy's Laboratories launches Amlodipine Besylate and Atorvastatin Calcium Tablets

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Calcium-channel blocker and antibiotic intake linked with small but greater risk of kidney injury

Calcium-channel blocker and antibiotic intake linked with small but greater risk of kidney injury

Study assesses relationship between BMI and CV events in hypertensive patients with diabetes

Study assesses relationship between BMI and CV events in hypertensive patients with diabetes

Diuretic-based antihypertensive therapy touted for obese

Diuretic-based antihypertensive therapy touted for obese

BMI may influence which blood pressure treatments work best

BMI may influence which blood pressure treatments work best

Latest polypill trial yields largest improvements yet

Latest polypill trial yields largest improvements yet

No added benefit of aliskiren-amlodipine fixed drug combination for hypertension

No added benefit of aliskiren-amlodipine fixed drug combination for hypertension

Weight gain or loss may also depend on medicines taken

Weight gain or loss may also depend on medicines taken

Ranbaxy signs consent decree with U.S. FDA

Ranbaxy signs consent decree with U.S. FDA

Ranbaxy introduces Atorvastatin-Amlodipine besylate tablets in the U.S.

Ranbaxy introduces Atorvastatin-Amlodipine besylate tablets in the U.S.